These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24434372)

  • 41. A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome.
    Ishiura Y; Fujimura M; Shiba Y; Ohkura N; Hara J; Kasahara K
    Pulm Pharmacol Ther; 2015 Dec; 35():28-33. PubMed ID: 26497109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice.
    Ogawa M; Sakonjo H; Kamei C
    Immunopharmacol Immunotoxicol; 2009; 31(4):601-6. PubMed ID: 19874229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of activin-A in cigarette smoke-induced inflammation and COPD.
    Verhamme FM; Bracke KR; Amatngalim GD; Verleden GM; Van Pottelberge GR; Hiemstra PS; Joos GF; Brusselle GG
    Eur Respir J; 2014 Apr; 43(4):1028-41. PubMed ID: 24232707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of mometasone furoate on nasal congestion model in rats.
    Ogawa M; Tsumuro T; Takubo M; Ueda Y; Yatsuzuka R; Kishi Y; Kamei C
    Pharmacology; 2009; 84(2):99-103. PubMed ID: 19602913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.
    Pirvulescu M; Manduteanu I; Gan AM; Stan D; Simion V; Butoi E; Calin M; Simionescu M
    Biochem Biophys Res Commun; 2012 Jun; 422(2):321-6. PubMed ID: 22575502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of pyocyanin-potentiated IL-8 release by steroids in bronchial epithelial cells.
    Pan NY; Hui WS; Tipoe GL; Taylor GW; Leung RY; Lam WK; Tsang KW; Mak JC
    Respir Med; 2006 Sep; 100(9):1614-22. PubMed ID: 16448811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of degradation products of mometasone furoate.
    Sahasranaman S; Issar M; Tóth G; Horváth G; Hochhaus G
    Pharmazie; 2004 May; 59(5):367-73. PubMed ID: 15212303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
    Holgate ST; Arshad H; Stryszak P; Harrison JE
    J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 15-Deoxy-prostaglandin J2 anti-inflammation in a rat model of chronic obstructive pulmonary disease and human bronchial epithelial cells via Nrf2 activation.
    Li XY; Luo BL; Wang LJ; Zhang WD; Liu ZG
    Genet Mol Res; 2015 Oct; 14(4):14037-42. PubMed ID: 26535717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.
    Agustí A; de Teresa L; De Backer W; Zvarich MT; Locantore N; Barnes N; Bourbeau J; Crim C
    Eur Respir J; 2014 Mar; 43(3):763-72. PubMed ID: 24114969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.
    Bollmeier SG; Prosser TR
    Ann Pharmacother; 2014 Feb; 48(2):250-7. PubMed ID: 24259654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of mometasone furoate / formoterol in the treatment of asthma.
    Westergaard CG; Porsbjerg C; Backer V
    Expert Opin Pharmacother; 2013 Feb; 14(3):339-46. PubMed ID: 23363416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
    Demirel I; Säve S; Kruse R; Persson K
    APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
    Ling C; Billig H
    Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative lack of systemic effects of mometasone furoate on Langerhans cells of mice after topical administration as compared with other glucocorticosteroids.
    Belsito DV; Baer RL; Schultz JM; Thorbecke GJ
    J Invest Dermatol; 1988 Sep; 91(3):219-23. PubMed ID: 3166025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults.
    Zeng M; Long XB; Cui YH; Liu Z
    Am J Rhinol Allergy; 2011; 25(6):e203-7. PubMed ID: 22185725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-κB inhibition.
    Kobayashi Y; Wada H; Rossios C; Takagi D; Higaki M; Mikura S; Goto H; Barnes PJ; Ito K
    J Pharmacol Exp Ther; 2013 Apr; 345(1):76-84. PubMed ID: 23359665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.